Who founded Emboline?

Emboline was founded by Amir Belson.

How much funding has Emboline raised?

Emboline has disclosed $66.9M raised across 2 rounds.

Where is Emboline headquartered?

Emboline is headquartered in Santa Cruz, US.

Emboline

Santa Cruz, US · Delaware corporation

Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.

Hardware Healthtech Medical Devices

Founders & leadership

Amir BelsonFounder & Chief Technology Officer

Mark CairesChief Financial Officer

Nicholas PappasNamed on SEC filing

Elton SatuskyNamed on SEC filing

Eric XiaoNamed on SEC filing

J. Casey McGlynnNamed on SEC filing

Scott RussellPresident & CEO

Issam MoussaNamed on SEC filing

Peng ChengNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$66.9M disclosed across 2 rounds · 2020–2021

▶$55.4MraisedJun 2021 · 14 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Nicholas PappasDirector
Elton SatuskyExecutive Officer
Amir BelsonExecutive Officer, Director
Eric XiaoDirector
J. Casey McGlynnExecutive Officer
Scott RussellExecutive Officer, Director
Issam MoussaDirector
Peng ChengDirector

Offering amount: $60.1M
Amount sold: $55.4M
First sale: May 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11.6MraisedFeb 2021 · 80 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Scott RussellExecutive Officer, Director
J. Casey McGlynnExecutive Officer
Issam D. MoussaDirector
Amir BelsonExecutive Officer, Director
William DaiDirector
Elton SatuskyExecutive Officer
Peng ChengDirector

Offering amount: $15M
Amount sold: $11.6M
First sale: Aug 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Boston Scientific7 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Emblok4 shared keywordsEmblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.

Companies competing with Emboline for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Emboline do?: Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.
Who founded Emboline?: Emboline was founded by Amir Belson.
How much funding has Emboline raised?: Emboline has disclosed $66.9M raised across 2 rounds.
Where is Emboline headquartered?: Emboline is headquartered in Santa Cruz, US.